Market Place
Sourcing Support
Vivoryon Therapeutics N.V. Shares Highlights from R&D Update
19 Feb 2025 //
GLOBENEWSWIRE
Vivoryon`s Ph 2 Data Supporting Varoglutamstat’s Kidney Function
08 Dec 2024 //
GLOBENEWSWIRE
Vivoryon Announces Presentation At ASN Kidney Week 2024
11 Oct 2024 //
GLOBENEWSWIRE
Vivoryon Announces Varoglutamstat Data In Diabetic Kidney Disease
18 Jul 2024 //
GLOBENEWSWIRE
Vivoryon Reports 2023 Results, Pipeline Updates
24 Apr 2024 //
GLOBENEWSWIRE
Vivoryon N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat
04 Mar 2024 //
GLOBENEWSWIRE
Vivoryon Provides Comprehensive Progress Report for VaroglutamstatProgram
26 Oct 2023 //
GLOBENEWSWIRE
Vivoryon Reports Positive Outcome from Board for Varoglutamstat
23 Oct 2023 //
GLOBENEWSWIRE
Vivoryon Shares Development Update Highlighting Progress of Varoglutamstat
16 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.